A Phase 1/2 Clinical Trial of an Alphavirus Replicon Vaccine for Influenza

NCT00440362 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: AVX502
BIOLOGICAL: AVX502
BIOLOGICAL: AVX502
BIOLOGICAL: AVX502
BIOLOGICAL: AVX502
BIOLOGICAL: AVX502
BIOLOGICAL: AVX502
BIOLOGICAL: AVX502
BIOLOGICAL: Placebo
BIOLOGICAL: Placebo
BIOLOGICAL: Placebo
BIOLOGICAL: Placebo

Sponsor

AlphaVax, Inc.